Reuters logo
7 months ago
BRIEF-Pain Therapeutics says sent a letter to Durect pursuant to development and license agreement dated as of December 19, 2002
December 8, 2016 / 9:45 PM / 7 months ago

BRIEF-Pain Therapeutics says sent a letter to Durect pursuant to development and license agreement dated as of December 19, 2002

1 Min Read

Dec 8 (Reuters) - Pain Therapeutics Inc :

* Pain Therapeutics Inc says on Dec 5, co sent a letter to Durect Corp pursuant to development and license agreement dated as of December 19, 2002

* Pain Therapeutics - letter provided durect with formal written notice that co is removing opioid drugs hydromorphone and oxymorphone as licensed products under DLA

* Says for avoidance of doubt, all terms and conditions of DLA remain in full force and effect with respect to remoxy

* Pain Therapeutics - letter does not alter terms of DLA regarding remaining licensed product, remoxy er (oxycodone capsules CII), or otherwise amend DLA Source text - bit.ly/2gpyw6m Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below